Titre:
  • Evaluation of the prognostic and predictive value of tumor-infiltrating lymphocytes (TILs) in a phase III randomized adjuvant breast cancer (BC) trial (BIG 2-98) of node-positive (N+) BC comparing the addition of docetaxel to doxorubicin (A-T) with doxorubicin (A)-only chemotherapy (CT)
Auteur:Loi, Sherene; Salgado, Roberto; Piette, F; Sirtaine, Nicolas; Van Eenoo, Françoise; Kammler, R; Rouas, Ghizlane; Francis, P; Crown, John; Nordenskjöld, B; Gutierrez, J; Andersson, M; Vila, Mireia Margeli; Jakesz, Raimund; Viale, Giuseppe; Quinaux, E; Di Leo, Angelo; Michiels, Stefan; Sotiriou, Christos; Piccart-Gebhart, Martine
Informations sur la publication:J Clin Oncol, ASCO Annual Meeting Proceedings, ASCO Annual meeting 2011(June, 2011: Chicago, Il, USA), Vol. 29, 15 Suppl, Part I, page (59)
Statut de publication:Publié, 2011-06
Sujet CREF:Cancérologie
Médecine pathologie humaine
Langue:Anglais